世界のペプチド治療薬市場は、2021年から2025年までの期間、6.95％のCAGRで拡大し、2025年には422億2000万ドルに達すると予想されます。この市場の成長を促す要因としては、癌の有病率の急増、医療費の増加、代謝障害の発生率の増加、高齢者人口の増加、承認されたペプチドを用いた治療薬の急増などが挙げられます。一方で、ジェネリックやバイオシミラーのペプチド治療薬の入手可能性、医薬品開発の高額なコスト、厳格な規制要件、ペプチド製造の複雑さなどが市場の成長を妨げる可能性があります。今後の市場動向としては、ジェネリック医薬品によるペプチドの量の増加、ペプチドAPIの受託製造の急速な拡大、新薬の研究開発への投資の増加などが予想されます。
世界のペプチド治療薬市場は、種類別、合成技術別、製造の種類別、用途別に分類されます。種類別には、革新的と一般的に分けられます。合成技術別には、固相法（SPPS）、液相法（LPPS）、ハイブリッド法に分類されます一方、製造の種類別には、受託製造と自社製造に分けられます。用途別に見ると、化学療法、胃腸病学、鎮痛、糖尿病、小児および新生児医療。その他の用途に分類されます。
最も急速に成長している地域市場は北米です。その要因としては、革新的なペプチド治療薬の開発のための研究開発活動の活発化と医療インフラの拡充、癌や糖尿病などの慢性疾患患者が多いためペプチド治療薬の使用が増加していることなどが挙げられます。
目次
1. Market Overview
1.1 Introduction
1.2 Manufacturing Process of Peptides
1.3 Classification of Peptides
1.4 Functional Classification of Therapeutic Peptides & Proteins
1.5 Examples of Peptide-based Drugs
1.6 Advantages and Disadvantages of Therapeutic Peptides
1.7 Source or Chemical Nature of Early Peptides
2. Impact of COVID-19
2.1 Adoption of Peptides in COVID-19 Related Research
2.2 Disruptions in Clinical Trials
3. Global Market Analysis
3.1 Global Peptide Therapeutics Market by Value
3.2 Global Peptide Therapeutics Market Forecast by Value
3.3 Global Peptide Therapeutics Market by Type
3.3.1 Global Innovative Peptide Therapeutics Market by Value
3.3.2 Global Innovative Peptide Therapeutics Market Forecast by Value
3.3.3 Global Generic Peptide Therapeutics Market by Value
3.3.4 Global Generic Peptide Therapeutics Market Forecast by Value
3.4 Global Peptide Therapeutics Market by Synthesis Technology
3.4.1 Global Solid Phase Peptide Synthesis Therapeutics Market by Value
3.4.2 Global Solid Phase Peptide Synthesis Therapeutics Market Forecast by Value
3.4.3 Global Liquid Phase Peptide Synthesis Therapeutics Market by Value
3.4.4 Global Liquid Phase Peptide Synthesis Therapeutics Market Forecast by Value
3.4.5 Global Hybrid Technology Synthesis Therapeutics Market by Value
3.4.6 Global Hybrid Technology Synthesis Therapeutics Market Forecast by Value
3.5 Global Peptide Therapeutics Market by Manufacturing Type
3.5.1 Global Outsourced Peptide Therapeutics Market Forecast by Value
3.5.2 Global In-house Peptide Therapeutics Market Forecast by Value
3.6 Global Peptide Therapeutics Market by Application
3.6.1 Global Metabolic Disorders Peptide Therapeutics Market by Value
3.6.2 Global Metabolic Disorders Peptide Therapeutics Market Forecast by Value
3.6.3 Global Oncology Peptide Therapeutics Market by Value
3.6.4 Global Oncology Peptide Therapeutics Market Forecast by Value
3.6.5 Global Gastrointestinal Disorders Peptide Therapeutics Market by Value
3.6.6 Global Gastrointestinal Disorders Peptide Therapeutics Market Forecast by Value
3.6.7 Global Cardiovascular Disorders Peptide Therapeutics Market by Value
3.6.8 Global Cardiovascular Disorders Peptide Therapeutics Market Forecast by Value
3.6.9 Global Neurological Disorders Peptide Therapeutics Market by Value
3.6.10 Global Neurological Disorders Peptide Therapeutics Market Forecast by Value
3.7 Global Peptide Therapeutics Market by Region
4. Regional Market Analysis
4.1 North America
4.1.1 North America Peptide Therapeutics Market by Value
4.1.2 North America Peptide Therapeutics Market Forecast by Value
4.1.3 The U.S. Peptide Therapeutics Market Forecast by Value
4.1.4 The U.S. Peptide Therapeutics Market Forecast by Type
4.2 Europe, Middle East & Africa
4.2.1 Europe, Middle East & Africa Peptide Therapeutics Market by Value
4.2.2 Europe, Middle East & Africa Peptide Therapeutics Market Forecast by Value
4.3 Asia Pacific
4.3.1 Asia Pacific Peptide Therapeutics Market by Value
4.3.2 Asia Pacific Peptide Therapeutics Market Forecast by Value
4.4 Latin America
4.4.1 Latin America Peptide Therapeutics Market by Value
4.4.2 Latin America Peptide Therapeutics Market Forecast by Value
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Surging Prevalence of Cancer
5.1.2 Rising Healthcare Expenditure
5.1.3 Growing Incidence of Metabolic Disorders
5.1.4 Increasing Geriatric Population
5.1.5 Accelerating Number of Approved Peptide-based Therapeutic Drugs
5.2 Key Trends and Developments
5.2.1 Expanding Volume of Peptides driven by Generics
5.2.2 Rapid Adoption of Outsourced Peptide API
5.2.3 Rising Investments in Research and Development of Novel Drugs
5.3 Challenges
5.3.1 Availability of Generic or Biosimilar Peptide Therapeutic Drugs
5.3.2 High Cost of Developing Drugs and Stringent Regulatory Requirements
5.3.3 Production Complexity of Peptides
6. Competitive Landscape
6.1 Global Market
6.1.1 Revenue Comparison of Key Players
6.1.2 Market Capitalization Comparison of Key Players
6.1.3 R&D Comparison of Key Players
7. Company Profiles
7.1 Novartis International AG
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.2 GlaxoSmithKline PLC
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategies
7.3 Bristol Myers Squibb Co.
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategies
7.4 Amgen Inc.
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategies
7.5 Eli Lilly and Company
7.5.1 Business Overview
7.5.2 Financial Overview
7.5.3 Business Strategies
7.6 PolyPeptide Group AG
7.6.1 Business Overview
7.6.2 Financial Overview
7.6.3 Business Strategies
List of Figures
Manufacturing Process of Peptides
Classification of Peptides
Functional Classification of Therapeutic Peptides & Proteins
Advantages and Disadvantages of Therapeutic Peptides
Global Most Affected Clinical Trials by Therapy Area (2020)
Global Peptide Therapeutics Market by Value (2016-2020)
Global Peptide Therapeutics Market Forecast by Value (2021-2025)
Global Peptide Therapeutics Market by Type (2020)
Global Innovative Peptide Therapeutics Market by Value (2016-2020)
Global Innovative Peptide Therapeutics Market Forecast by Value (2021-2025)
Global Generic Peptide Therapeutics Market by Value (2016-2020)
Global Generic Peptide Therapeutics Market Forecast by Value (2021-2025)
Global Peptide Therapeutics Market by Synthesis Technology (2020)
Global Solid Phase Peptide Synthesis Therapeutics Market by Value (2016-2020)
Global Solid Phase Peptide Synthesis Therapeutics Market Forecast by Value (2021-2025)
Global Liquid Phase Peptide Synthesis Therapeutics Market by Value (2016-2020)
Global Liquid Phase Peptide Synthesis Therapeutics Market Forecast by Value (2021-2025)
Global Hybrid Technology Synthesis Therapeutics Market by Value (2016-2020)
Global Hybrid Technology Synthesis Therapeutics Market Forecast by Value (2021-2025)
Global Peptide Therapeutics Market by Manufacturing Type (2020)
Global Outsourced Peptide Therapeutics Market Forecast by Value (2020-2025)
Global In-house Peptide Therapeutics Market Forecast by Value (2020-2025)
Global Peptide Therapeutics Market by Application (2020)
Global Metabolic Disorders Peptide Therapeutics Market by Value (2016-2020)
Global Metabolic Disorders Peptide Therapeutics Market Forecast by Value (2021-2025)
Global Oncology Peptide Therapeutics Market by Value (2016-2020)
Global Oncology Peptide Therapeutics Market Forecast by Value (2021-2025)
Global Gastrointestinal Disorders Peptide Therapeutics Market by Value (2016-2020)
Global Gastrointestinal Disorders Peptide Therapeutics Market Forecast by Value (2021-2025)
Global Cardiovascular Disorders Peptide Therapeutics Market by Value (2016-2020)
Global Cardiovascular Disorders Peptide Therapeutics Market Forecast by Value (2021-2025)
Global Neurological Disorders Peptide Therapeutics Market by Value (2016-2020)
Global Neurological Disorders Peptide Therapeutics Market Forecast by Value (2021-2025)
Global Peptide Therapeutics Market by Region (2020)
North America Peptide Therapeutics Market by Value (2016-2020)
North America Peptide Therapeutics Market Forecast by Value (2021-2025)
The U.S. Peptide Therapeutics Market Forecast by Value (2020-2025)
The U.S. Peptide Therapeutics Market by Type (2020-2025)
Europe, Middle East & Africa Peptide Therapeutics Market by Value (2016-2020)
Europe, Middle East & Africa Peptide Therapeutics Market Forecast by Value (2021-2025)
Asia Pacific Peptide Therapeutics Market by Value (2016-2020)
Asia Pacific Peptide Therapeutics Market Forecast by Value (2021-2025)
Latin America Peptide Therapeutics Market by Value (2016-2020)
Latin America Peptide Therapeutics Market Forecast by Value (2021-2025)
Global Cancer Prevalence (2018-2023)
Global Healthcare Expenditure Per Capita (2016-2020)
Global Diabetes Prevalence (2010-2045)
Global Population Ages 65 Years and Above (2016-2020)
Number of Approved/Launched Peptide Therapeutic Drugs Worldwide (2020-2025)
Global GLP-1 Market Development (2018-2027)
Global In-House vs. Outsourced Peptide API Market Development (2020-2025)
Global Spending on Pharmaceutical Research and Development (2018-2026)
Global Biosimilar Therapeutic Peptides Market (2020-2025)
Novartis International AG Net Sales and Net Income (2016-2020)
Novartis International AG Net Sales by Segment (2020)
Novartis International AG Net Sales by Region (2020)
GlaxoSmithKline PLC Turnover and Profit (2016-2020)
GlaxoSmithKline PLC Turnover by Segment (2020)
GlaxoSmithKline PLC Turnover by Region (2020)
Bristol Myers Squibb Co. Total Revenue and Net Earnings (2016-2020)
Bristol Myers Squibb Co. Total Revenue by Region (2020)
Amgen Inc. Revenue and Net Income (2016-2020)
Amgen Inc. Revenue by Region (2020)
Eli Lilly and Company Revenue and Net Income (2016-2020)
Eli Lilly and Company Revenue by Region (2020)
PolyPeptide Group AG Revenue and Net Income (2018-2020)
PolyPeptide Group AG Revenue by Segment (2020)
PolyPeptide Group AG Revenue by Region (2020)
List of Tables
Difference between Peptides, Small Molecules & Biologics
Examples of Peptide-based Drugs Available in the Market
Source or Chemical Nature of Early Peptides
Synthetic Peptides in Development of COVID-19 (2020)
Revenue Comparison of Key Players (2020)
Market Capitalization Comparison of Key Players (2021)
R&D Comparison of Key Players (2020)
